MiniMed Group (NASDAQ:MMED) Price Target Raised to $28.00

MiniMed Group (NASDAQ:MMED) had its price target increased by Mizuho from $26.00 to $28.00 in a report published on Thursday morning,Benzinga reports. The brokerage currently has an outperform rating on the stock.

Other equities analysts also recently issued reports about the company. Wells Fargo & Company increased their target price on MiniMed Group from $22.00 to $26.00 and gave the stock an “overweight” rating in a research report on Wednesday, September 2nd. Bank of America upped their price objective on shares of MiniMed Group from $24.00 to $28.00 and gave the company a “buy” rating in a research note on Wednesday, September 2nd. Citigroup increased their price objective on shares of MiniMed Group from $23.00 to $26.00 and gave the stock a “buy” rating in a report on Wednesday, September 2nd. UBS Group raised their target price on shares of MiniMed Group from $25.00 to $28.00 and gave the stock a “buy” rating in a research report on Wednesday, September 2nd. Finally, BTIG Research boosted their target price on shares of MiniMed Group from $25.00 to $28.00 and gave the company a “buy” rating in a report on Tuesday, September 1st. Thirteen equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $24.00.

MiniMed Group Stock Down 0.5%

MMED stock opened at $19.71 on Thursday. The stock has a market capitalization of $5.55 billion and a price-to-earnings ratio of -28.99. MiniMed Group has a 52-week low of $10.65 and a 52-week high of $24.43. The stock’s fifty day simple moving average is $20.63 and its 200-day simple moving average is $16.42.

Hedge Funds Weigh In On MiniMed Group

Several institutional investors and hedge funds have recently made changes to their positions in MMED. Parkside Financial Bank & Trust acquired a new stake in shares of MiniMed Group during the second quarter worth approximately $28,000. Legal & General Group Plc acquired a new stake in MiniMed Group in the second quarter valued at $91,000. The Manufacturers Life Insurance Company bought a new position in MiniMed Group during the 2nd quarter valued at $185,000. WINTON GROUP Ltd bought a new position in MiniMed Group during the 2nd quarter valued at $273,000. Finally, Punch & Associates Investment Management Inc. acquired a new position in MiniMed Group during the 2nd quarter worth $292,000.

MiniMed Group Company Profile

We are a scaled global medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. Since our founding more than 40 years ago, we have pioneered groundbreaking innovation and served the needs of our customers across the globe in service of our mission to make every day a better day for people with diabetes. Today, we are the only player in the market that commercializes all parts of an integrated diabetes management system.